机构地区:[1]首都医科大学附属北京安贞医院耳鼻咽喉头颈外科,北京100029 [2]首都儿科研究所耳鼻咽喉头颈外科
出 处:《临床耳鼻咽喉头颈外科杂志》2021年第12期1057-1062,共6页Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基 金:北京学者计划(NO.051);北京市医院管理中心“使命”人才计划(No:SML20190601)。
摘 要:目的:分析上呼吸道感染后嗅觉障碍(PVOD)患者主客观嗅觉功能测试结果,评估预后因素,为临床诊疗提供依据。方法:回顾性分析就诊于首都医科大学附属北京安贞医院门诊的PVOD患者,给予嗅觉训练治疗4个月,对患者治疗前后进行Sniffin’Sticks嗅觉测试,根据嗅觉功能改善情况分为嗅觉功能改善组和嗅觉功能无改善组,分析患者一般情况、Sniffin’Sticks嗅觉测试和事件相关电位(ERPs)结果,评估嗅觉预后相关因素。结果:63例PVOD患者的嗅觉改善率为52.38%(33/63)。与嗅觉功能无改善组比较,嗅觉功能改善组病程短(P<0.001),治疗前嗅觉功能好(P<0.001),嗅觉阈值低(P<0.001)。嗅觉事件相关电位(oERPs)和三叉神经事件相关电位(tERPs)的引出率分别为52.38%(33/63)和87.30%(55/63),嗅觉功能改善组oERPs引出率明显高于嗅觉功能无改善组(P<0.05),而tERPs引出率差异无统计学意义(P>0.05)。嗅觉功能改善组oERPs的N1波潜伏期(N1L)和P2波潜伏期(P2L)高于嗅觉功能无改善组(P<0.05),N1波振幅(N1A)和P2波振幅(P2A)差异无统计学意义(P>0.05)。tERPs的N1波和P2波振幅及潜伏期两组间差异无统计学意义(P>0.05)。经多因素Logistic回归分析,治疗前阈值(OR=21.376,95%CI:2.172~210.377,P=0.009)、oERPs的N1L(OR=0.994,95%CI:0.988~0.999,P=0.029)和病程(OR=0.607,95%CI:0.405~0.920,P=0.016)与嗅觉预后显著相关。结论:嗅觉障碍病程、嗅觉障碍严重程度、嗅觉功能阈值、oERPs的N1L可作为评估PVOD患者预后的指标。而年龄、嗅觉辨别能力、识别能力、oERPs的振幅和tERPs各波值等对预后评估价值较小。Objective: To analyzed the results of olfactory function test in patients with post-viral olfactory dysfunction(PVOD), and evaluated the prognostic factors, so as to provide a basis for clinical diagnosis and treatment. Methods: This study included patients who were diagnosed with PVOD at least one year ago in Beijing Anzhen Hospital and whose telephone interviews of subjective olfactory function were available. The general condition of the patients, the results Sniffin’ Sticks olfactory test and the event-related potentials(ERPs) were analyzed in different improvement groups. This study retrospectively analyzed PVOD patients treated in the outpatient department of Beijing Anzhen Hospital. They were given olfactory training for 4 months. The Sniffin’ Sticks test was performed on the patients before and after the treatment. The Sniffin’ Sticks test and event-related potentials(ERPs) results were used to evaluate the prognostic factors. Results: In this study, the olfactory improvement rate of 63 PVOD patients was 52.38%(33/63). Compared to the non-improvement group, the course of disease in the group with improved subjective olfactory function was significantly shorter(P<0.001), the initial olfactory function was significantly better(P<0.001), and the olfactory threshold was much lower(P<0.001). The presence of olfactory event-related potentials and trigeminal ERPs(tERPs) were 52.38%(33/63) and 87.30%(55/63), respectively. The presence of oERPs in the olfactory function improvement group was significantly higher than that in the non-improvement group(P<0.05), but there was no difference in the presence of tERPs(P>0.05). Latency of N1 and P2 waves in oERPs with improvement group(ON1 L, OP2 L) were longer than those in the non-improvement group(P<0.05), N1 and P2 wave amplitudes(ON1 A, OP2 A) had no difference(P>0.05). The N1 and P2 amplitudes and latency of tERPs showed no difference between the two groups. Multivariate Logistic regression analysis showed that threshold value before treatment(OR=21.376, 95%CI
关 键 词:上呼吸道感染后嗅觉障碍 嗅觉障碍 事件相关电位检查 预后因素
分 类 号:R765.63[医药卫生—耳鼻咽喉科]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...